Literature DB >> 24117897

Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.

Zhu-Lin Luo1, Li-Jun Tang, Tao Wang, Rui-Wu Dai, Jian-Dong Ren, Long Cheng, Ke Xiang, Fu-Zhou Tian.   

Abstract

BACKGROUND AND AIM: Oxidative stress and inflammation play important roles in the progression from simple fatty liver to non-alcoholic steatohepatitis (NASH). The aim of this work was to investigate whether treatment with hydrogen sulfide (H2 S) prevented NASH in rats through abating oxidative stress and suppressing inflammation.
METHODS: A methionine-choline-deficient (MCD) diet rat model was prepared. Rats were divided into three experimental groups and fed for 8 weeks as follows: (i) control rats; (ii) MCD-diet-fed rats; (iii) MCD-diet-fed rats treated with NaHS (intraperitoneal injection of 0.1 mL/kg/day of 0.28 mol/L NaHS, a donor of H2 S).
RESULTS: MCD diet impaired hepatic H2 S biosynthesis in rats. Treatment with H2 S prevented MCD-diet-induced NASH, as evidenced by hematoxylin and eosin staining, reduced apoptosis and activities of alanine aminotransferase and aspartate aminotransferase, and attenuated hepatic fat accumulation in rats. Treatment with H2 S abated MCD-diet-induced oxidative stress through reducing cytochrome p4502E1 expression, enhancing heme oxygenase-1 expression, and suppressing mitochondrial reactive oxygen species formation, and suppressed MCD-diet-induced inflammation through suppressing activated nuclear factor κB signaling and reducing interleukin-6 and tumor necrosis factor α expressions. In addition, treatment of MCD-diet fed rats with H2 S had a beneficial modulation on expression profiles of fatty acid metabolism genes in livers.
CONCLUSIONS: Treatment with H2 S prevented NASH induced by MCD diet in rats possibly through abating oxidative stress and suppressing inflammation.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  hydrogen sulfide; inflammation; methionine-choline deficient diet; non-alcoholic steatohepatitis; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24117897     DOI: 10.1111/jgh.12389

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  16 in total

1.  Hydrogen sulfide and nonalcoholic fatty liver disease.

Authors:  Panzhi Wang; Liming Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

Review 2.  Hydrogen sulfide and hepatic lipid metabolism - a critical pairing for liver health.

Authors:  Julie J Loiselle; Guangdong Yang; Lingyun Wu
Journal:  Br J Pharmacol       Date:  2018-12-28       Impact factor: 8.739

3.  Treatment with hydrogen sulfide attenuates sublesional skeletal deterioration following motor complete spinal cord injury in rats.

Authors:  X Yang; D Hao; H Zhang; B Liu; M Yang; B He
Journal:  Osteoporos Int       Date:  2016-09-03       Impact factor: 4.507

Review 4.  Hydrogen sulphide in liver glucose/lipid metabolism and non-alcoholic fatty liver disease.

Authors:  Inês Mateus; Carina Prip-Buus
Journal:  Eur J Clin Invest       Date:  2021-10-25       Impact factor: 5.722

Review 5.  Chemical Biology of H2S Signaling through Persulfidation.

Authors:  Milos R Filipovic; Jasmina Zivanovic; Beatriz Alvarez; Ruma Banerjee
Journal:  Chem Rev       Date:  2017-11-07       Impact factor: 60.622

Review 6.  The Impact of H2S on Obesity-Associated Metabolic Disturbances.

Authors:  Ferran Comas; José María Moreno-Navarrete
Journal:  Antioxidants (Basel)       Date:  2021-04-21

7.  Exogenous hydrogen sulfide mitigates the fatty liver in obese mice through improving lipid metabolism and antioxidant potential.

Authors:  Dongdong Wu; Nairui Zheng; Kunqing Qi; Huijun Cheng; Ziqiang Sun; Biao Gao; Youjing Zhang; Wuyan Pang; Chaoshen Huangfu; Shaoping Ji; Mengzhou Xue; Ailing Ji; Yanzhang Li
Journal:  Med Gas Res       Date:  2015-01-10

8.  Hyperpolarized 13C Spectroscopic Evaluation of Oxidative Stress in a Rodent Model of Steatohepatitis.

Authors:  David M Wilson; Valentina Di Gialleonardo; Zhen J Wang; Valerie Carroll; Cornelius Von Morze; Andrew Taylor; Victor Sai; Mark VanCriekinge; Robert Bok; Michael A Ohliger; Kayvan R Keshari
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

9.  Engineering a highly selective probe for ratiometric imaging of H2S n and revealing its signaling pathway in fatty liver disease.

Authors:  Wei Li; Lu Wang; Shulu Yin; Huanhua Lai; Lin Yuan; Xiaobing Zhang
Journal:  Chem Sci       Date:  2020-07-09       Impact factor: 9.825

10.  Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.

Authors:  Ying Hong; Lili Sheng; Jing Zhong; Xin Tao; Weize Zhu; Junli Ma; Juan Yan; Aihua Zhao; Xiaojiao Zheng; Gaosong Wu; Bingbing Li; Bangxing Han; Kan Ding; Ningning Zheng; Wei Jia; Houkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.